AI SaaS in Pharma: Accelerating Drug Discovery
AI‑powered SaaS accelerates drug discovery by turning scattered biology, chemistry, and lab data into a governed system of action. The durable blueprint: ground hypotheses in permissioned literature, patents, omics, structures, and assay data; use calibrated models for target prioritization, virtual screening, generative design under constraints, and ADMET/PK prediction; simulate project and safety risks; then execute … Read more